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Abstract
Background: Crystalline silica is considered as one of the most common and serious occupational hazards to
workers’ health. Although its association with lung cancer has been studied for many decades, the conclusion
remains somewhat controversial. Our objectives are to review and summarize the epidemiological evidence on the
relationship between occupational silica exposure and risk of lung cancer and to provide an update on this major
occupational health concern.
Methods: Eligible studies up to 29 April 2016 were identified. Pooled effect estimates were calculated according to
the reported outcome and the study design. Cohort, case control and proportional mortality studies were examined
separately. Studies reporting results according to silicotic status were grouped together and analyzed. Due to the
significant amount of heterogeneity expected, random effects models were implemented. Subgroup and meta-
regression analyses (both univariate and multivariate) were performed in an attempt to explain heterogeneity.
Studies which had adequate exposure characterization were selected to find out whether there was an exposure-
response relationship between silica and lung cancer.
Results: The risk of lung cancer was found to be elevated in both silicotics and non-silicotics. The pooled standardized
mortality ratio (SMR) was 2.32 with a 95 % confidence interval (95 % CI) of 1.91–2.81 and 1.78 (95 % CI 1.07–2.96)
respectively. The pooled standardized incidence ratio (SIR) was 2.49 (95 % CI 1.87–3.33) and 1.18 (95 % CI 0.86–1.62)
respectively. Subgroup analysis showed that workers in the mining industry had the highest risk of lung cancer with
a pooled SMR of 1.48 (95 % CI 1.18–1.86) and the weakest association was seen in potteries with a pooled SMR of 1.14
(95 % CI 1.05–1.23). A positive exposure-response relation was found between cumulative silica exposure and risk of
lung cancer.
Conclusion: The results of our meta-analysis supported the carcinogenic role of silica on the lungs, which was more
pronounced at higher levels of exposure, in the presence of silicosis and in the mining industry. Further research is
needed to evaluate whether non-silicotics are truly at risk, whether a predisposing factor would explain this potential
risk, and to determine the mechanism of carcinogenicity of silica in humans.
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Background
Crystalline silica is one of the commonest minerals on
earth and a major ingredient in sand, granite, soil and
glass. Traditionally, silica exposure occurs in workplaces
such as coal and metal mining, metallurgy, construction
industry and manufacturing of building materials, glass
and clay. Recent reports indicated that more than 33
million workers in China [1] and India [2], more than
3.2 million workers in Europe [3] and about 1.7 million
workers in the United States [4] are exposed to crystal-
line silica dust. Currently, environmental exposure to
ambient silica dust caught more attention, not only during
agricultural activities, but also during natural sandstorms
and volcanic explosions [5, 6]. Silica exposure causes
many adverse health effects including silicosis, cardiovas-
cular diseases, tuberculosis, malignancies, autoimmune
diseases and renal disorders and increased mortality, mak-
ing it a high-priority public health concern [7].
The possible carcinogenicity of silica became a subject
of intense debate in the scientific community in the
1980s, especially after the publication of epidemiological
studies by Westerholm in 1980 [8] and Finkelstein et al.
in 1982 [9], a literature review by Goldsmith et al. in 1982
[10] and presentation of new information at a 1984 sym-
posium in North Carolina [11]. This triggered the publica-
tion of further studies on cancer mortality and morbidity
in silica-exposed occupational groups. In 1997, based on a
review of these studies, the International Agency for
Research on Cancer (IARC) classified crystalline silica in
the form of quartz or cristobalite as carcinogenic to
humans (Group 1) [12]. However, the IARC working
group also stated that the carcinogenicity was not found
in all industrial circumstances, and their conclusion
remained somewhat controversial.
The latest IARC report in 2012 reported seven meta-
analyses conducted on this topic [13]. We noted that the
issue of between-study heterogeneity was either not ad-
dressed at all or not dealt with in sufficient detail in
these meta-analyses. Also, since the publication of the
last meta-analysis on the relation between occupational
silica exposure and lung cancer in 2009, more than 10
potentially relevant epidemiological studies have been
conducted.
In our paper, we have combined epidemiological data
from relevant studies published till date to evaluate the
risk of lung cancer due to silica dust exposure and we
have attempted to explain heterogeneity through sub-
group and meta-regression analyses. We have also per-
formed an exposure-response analysis by identifying
studies which had well-characterized exposure data.
Methods
The meta-analysis was conceived and performed in
accordance with the Preferred Reporting Items for
Systematic Reviews and Meta-Analyses (PRISMA)
guidelines [14].
Search strategy
We searched MEDLINE and EMBASE databases from
January 1982 through 29 April 2016 using the search
terms “lung cancer”, “silica”, “silicosis”, “risk”, “inci-
dence” and “mortality” with variation in term construct
to identify epidemiological studies published in the lit-
erature which evaluated the relationship between silica
exposure and lung cancer in workers, irrespective of
their silicotic status (Additional file 1). Reference lists of
the identified articles were also screened for potentially
eligible studies.
The following inclusion criteria were used for the
analysis:
 The article had to have been published in English;
 The study had to have had a cohort or case-control
or proportional mortality study design;
 Lung cancer should have been reported as a
major outcome;
 The article had to have reported original results
along with confidence intervals in the form of
standardized mortality ratio (SMR) or standardized
incidence ratio (SIR) or odds ratio (OR) or
proportional mortality ratio (PMR) or mortality
odds ratio (MOR) or relative risk (RR) with their
corresponding 95 % confidence interval.
Reviews, autopsy studies, comments, editorials, studies
with insufficient quantitative data required for the ana-
lysis (no risk estimate, no confidence intervals) and
those overlapping with studies which were already con-
sidered, were excluded.
When a particular study was reported in several
papers, the most recently-published reference was used
unless the required data was reported in a previous
paper and not in the latest-published one.
Data extraction
For each study, the following data was extracted: geo-
graphical location, year of publication, industrial setting,
study design, total number of subjects, exposure assess-
ment (including level and duration of exposure to silica
dust), outcome examined, study period (including the
start date, end date and duration of follow-up), person-
years of follow-up, covariates adjusted for, potential
occupational carcinogens including radon, arsenic, as-
bestos, diesel, polycyclic aromatic hydrocarbons (PAH),
talc, cadmium and amphiboles, number of lung cancer
cases, total number of deaths and number of deaths due
to lung cancer, measure of association and effect esti-
mates with corresponding 95 % confidence interval (CI).
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Two authors worked independently for study selection
and data extraction. Any disagreement was resolved after
a team discussion. The list of included studies was made
in consensus.
Assessing study quality
We used the Newcastle-Ottawa Assessment Scale (NOS)
for assessing the methodological quality of observational
studies [15]. The scale consists of three main categories
including selection of study population, comparability of
subjects and ascertainment of exposure for case-control
studies or ascertainment of outcome for cohort and pro-
portional mortality studies. Scores of 0–3, 4–6 and 7–9
were assigned to low, moderate and high quality studies
respectively.
Statistical analysis
Studies were pooled together according to the outcome
examined which could be incidence or mortality, the
study design which could be cohort or case-control or
proportional mortality study design and the measure of
association. When a study reported results stratified by
race, gender, industrial setting and silicotic status, they
were treated as two separate reports for analysis. Studies
which gave risk estimates according to silicotic status
were grouped and analyzed separately. Statistical analysis
was performed on the natural logarithm (ln) of the risk
estimate so as to approximate its sampling distribution
to a normal one. The difference between the upper and
lower limits of the confidence intervals was transformed
to the log scale and the standard error was calculated by
dividing the transformed interval by 3.92 [16]. Random
effects model was used to calculate the pooled effect es-
timates since a high level of heterogeneity was expected.
Heterogeneity between studies was quantified by two
methods namely the chi-squared test (Q test) for hetero-
geneity, reported by its p value, and the variability due to
heterogeneity (I2 statistic), reported as a percentage in this
paper [17]. We performed subgroup and meta-regression
analyses to try to explain any observed between-study het-
erogeneity. In subgroup analysis, the studies were catego-
rized into subgroups based on the predefined covariates.
In meta-regression, we investigate the relationship be-
tween the covariates and the observed outcome [18]. The
proportion of variance explained (R2) was used to quantify
the amount of heterogeneity accounted for by each covari-
ate. It was calculated as the percentage of ratio of variance
explained to the total amount of variance. Both univariate
and multivariate meta-regression models were used to try
to lower the variability due to heterogeneity (I2) to the
minimum level and to bring the p value of Q close to 1.
Heterogeneity should be completely absent (I2 is 0 and
p value of Q is 1) for an ideal comparison [19]. Differ-
ences in exposure assessment, study design and quality,
data collection processes, outcome assessment, selec-
tion of subjects and definition of confounding factors
often account for significant between-study heterogen-
eity [16]. Based on this statement, the covariates con-
sidered were year of publication, presence of at least
one confounding factor, adjustment for smoking, indus-
trial setting, geographical location, NOS score, cumula-
tive silica dust exposure level, duration of exposure,
concentration of silica dust, person-years of follow-up,
number of subjects and total number of deaths. For
sensitivity analyses, we assessed the influence of indi-
vidual studies on the pooled estimate by omitting each
study in turn (leave-one-out analysis). Publication bias
was assessed graphically by means of funnel plots and
quantitatively by Egger’s linear regression method [20].
For the exposure-response analyses, we used the aver-
age cumulative silica dust exposure as covariate and the
risk estimate of the corresponding study as the effect.
No imputation was made in relating the effect estimate
to the exposure level. Statistical analysis was done using
R software version 3.1.2 (2014-10-31) [21] with the
‘metafor’ package version 1.9-5 [22].
The levels of significance for all statistical tests were
assumed to be equal to or less than 0.05, except in the
case of heterogeneity testing whereby the level of signifi-
cance was assumed to be equal to or less than 0.10 [17].
Results
Characteristics of studies and bias assessment
The PRISMA flowchart for the selection of studies is
shown in Fig. 1. The initial search criteria yielded 227 ci-
tations from the databases. 58 additional records were
further identified from references of related articles.
After removing duplicates, we were left with 273 re-
cords. Preliminary screening of abstracts eliminated 158
studies. Of the remaining 115 articles, 30 were excluded
for the following reasons: 6 articles were found to be ei-
ther reviews, editorials, comments or autopsy studies, 11
papers had no risk estimate data, 2 articles did not give
the confidence intervals of the effect estimate, 2 articles
did not report lung cancer as outcome and 9 articles had
overlapping populations with selected studies. After exclu-
sion of these 30 studies, 85 articles were left and included
in the final main quantitative synthesis [9, 10, 23–104].
The study of Puntoni et al. [105], which was excluded
from the main synthesis due to overlap with the study
cohort of Merlo et al. [66], was included in the list of sili-
cotic studies since it contained the risk estimate based on
silicotic status whereas the study by Merlo et al. had the
risk estimate of the whole cohort and not according to
silicotic status.
After categorization of the studies by outcome
assessed, study type and measure of association there
were 63 cohort studies reporting mortality due to lung
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cancer in the form of SMR as measure of association, 19
cohort studies reporting incidence of lung cancer in the
form of SIR, 1 cohort study reporting incidence in the
form of RR, 3 case-control studies reporting mortality in
the form of MOR, 9 case-control studies reporting inci-
dence in the form of OR, 5 case-control studies report-
ing mortality in the form of OR and 2 proportional
mortality studies or PMR. The characteristics of all in-
cluded studies are shown in Additional file 2.
Most studies comprised males only and a mere few in-
cluded both males and a small proportion of females
(around 10 %). Only exceptions were the studies of
Zhang et al. [104] and Smailyte et al. [84] with 26 and
31 % women respectively. Nine papers reported 2 or
more results stratified by industrial setting, sex, silicotic
status and racial background. Forty-one studies were
conducted in European countries, 18 in the United
States, 21 in Asian countries, 9 in Canada, 3 in Australia
and 1 in South Africa. The industries of concern were
mining, foundry, pottery and ceramic, refractory brick and
diatomaceous earth processing, granite which included
sand and quarry, cement production and construction.
The total number of studies available for analysis accord-
ing to silicotic status was 34. The characteristics of
silicotic and non-silicotic studies are described in Table 1.
The results of the study quality assessment are pre-
sented in Additional file 3. Ten articles were deemed to
be of low quality, 49 articles were found to be of
medium quality and 26 articles were shown to be of high
quality. The median score for all 85 articles was 5.3 out
of a maximum of 9.
As demonstrated graphically by the funnel plots in
Additional files 4, 5 and 6, there was evidence of publi-
cation bias for studies reporting mortality in the form of
SMR (p = 0.024 for Egger’s regression test) but no evi-
dence of publication bias for studies reporting incidence
in the form of SIR (p = 0.238) and OR (p = 0.457).
Data analysis
Using the random effects model, the pooled estimate was
1.55 (95 % CI 1.38–1.75) for SMR studies, 1.68 (95 % CI
1.45–1.96) for SIR studies, 1.10 (95 % CI 0.89–1.36) for
PMR studies, 1.69 (95 % CI 1.26–2.26) for MOR studies,
and 1.34 (95 % CI 1.24–1.46) for case-control studies
reporting incidence as outcome and 1.82 (95 % CI
1.25–2.66) for case-control studies reporting mortality
as outcome. The risk estimate in each category was statis-
tically significant (p < 0.05) except in the category of PMR
studies (p = 0.38). The results of the SMR, SIR and OR
studies with incidence as outcome are illustrated in forest
Fig. 1 The PRISMA flowchart for the selection of studies
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Table 1 Characteristics of silicotic and non-silicotic studies












1 Amandus, 1995 [25] USA Mixed Age, sex, race, talc, asbestos 760 Mortality SMR, silicotic 2.30 (1.50–3.40)
2 Berry, 2003 [28] Australia Mixed Age, sex, calendar period, smoking 1467 Mortality SMR, silicotic 1.90 (1.50–2.30) 94
3 Carta, 2001 [31] Sardinia Mine & quarries Age, sex, calendar period 724 Mortality SMR, silicotic 1.37 (0.98–1.91) 34
4 Chan, 2000 [33] Hong Kong Mixed Age, sex, calendar period 1502 Mortality SMR, silicotic 1.94 (1.35–2.70) 33
5 Chen, 1992 [34] China Mixed Age, sex 70179 Mortality SMR, silicotic 1.22 (0.90–1.60)
6 Chen, 1990 [35] China Iron mine Age, sex 1226 Mortality SMR, silicotic 5.30 (2.90–8.80) 14
Mortality SMR, non-silicotic 2.90 (1.60–4.70) 15
7 Chen, 2006 [37] China Mine Age, sex 932 Mortality SMR, silicotic 4.13 (3.15–5.29)
Mortality SMR, non-silicotic 1.96 (1.50–2.73)
8 Chia, 1991 [39] China granite Age, sex, calendar period 159 Incidence SIR, silicotic 2.01 (0.92–3.81) 9
9 Chiyotani, 1990 [40] Japan Mixed Age, sex 1941 Mortality SMR, silicotic 6.03 (5.29–6.77) 44
10 Finkelstein, 1982 [10] Canada mine Age, sex, calendar period 1190 Mortality SMR, silicotic 2.30 (1.80–3.00) 62
11 Finkelstein, 1995 [43] Canada Mixed Age, sex 328 Incidence SIR, silicotic 2.55 (1.43–8.28) 15
Incidence SIR, non-silicotic 0.90 (0.51–1.47) 16
12 Goldsmith, 1995 [49] USA Mixed Age, sex, calendar period 590 Mortality SMR, silicotic 1.90 (1.35–2.60) 39
13 Infante- Rivard, 1989 [54] Canada Mixed Age, sex, calendar period 1072 Mortality SMR, silicotic 3.47 (3.11–3.90) 83
14 Marinaccio, 2006 [63] Italy Mixed Age, sex, calendar period 14929 Mortality SMR, silicotic 1.10 (1.03–1.18) 798
15 Mehnert, 1990 [64] Germany quarry age, sex 2475 Mortality SMR, silicotic 1.83 (0.84–3.48) 9
Mortality SMR, non-silicotic 0.91 (0.54–1.44) 18
16 Merlo, 1995 [67] Italy Mixed Age, sex, calendar period 450 Mortality SMR, silicotic 3.50 (2.44–4.87) 35
17 Ng, 1990 [71] Hong Kong Mixed Age, sex, PAH, asbestos 1419 Mortality SMR, silicotic 2.03 (1.35–2.93) 28
18 Partanen, 1994 [73] Finland Mixed Age, sex, calendar period 811 Incidence SIR, silicotic 2.89 (2.35–3.48) 190
19 Puntoni, 1988 [105] Italy Refractory brick Age, sex 231 Mortality SMR, silicotic 1.67 (0.61–3.64) 6
Mortality SMR, non-silicotic 2.08 (0.67–4.84) 5
20 Scarselli, 2011 [81] Italy Mixed Age, sex, calendar period 2034 Mortality SMR, silicotic 1.39 (1.17–1.64) 139
21 Sherson, 1991 [83] Denmark Foundry Age, sex, calendar period 6144 Incidence SIR, silicotic 1.71 (0.85–3.06) 11
Incidence SIR, non-silicotic 1.30 (1.07–1.47) 150
22 Tornling, 1991 [88] Sweden Ceramic Age, sex 280 Mortality SMR, silicotic 2.36 (1.07–4.48) 9
23 Tse, 2014 [90] Hong Kong Mixed Age, sex, calendar period 3202 Mortality SMR, silicotic 1.86 (1.59–2.17) 157













Table 1 Characteristics of silicotic and non-silicotic studies (Continued)
25 Westerholm, 1980 [9] Sweden Mixed Age, sex, calendar period 3610 Mortality SMR, silicotic 3.80 (2.30–5.80)
26 Westerholm, 1986 [99] Sweden Mixed Age, sex, calendar period 712 Mortality SMR, silicotic 5.38 (2.20–11.10) 7
27 Yu, 2008 [102] Hong Kong mixed Age, calendar period, smoking 2798 Mortality SMR, silicotic 1.56 (0.98–2.63) 86
28 Zambon, 1987 [103] Italy Mixed Age, sex, calendar period 1313 Mortality SMR, silicotic 2.39 (1.86–3.02) 70
Case-control studies
1 Forastiere, 1989 [45] Italy Mixed Age, sex, calendar period 595 Mortality MOR, silicotic 2.50 (1.20–4.60) 10
2 Fu, 1994 [46] China Tin mine Age, sex, smoking 267 Incidence OR, silicotic 2.03 (1.25–3.29)
3 Lagorio, 1990 [61] Italy Pottery Age, calendar period, smoking 391 Mortality OR, silicotic 3.90 (1.80–8.30)
Mortality OR, non-silicotic 1.40 (0.70–2.80)
4 Neuberger, 1988 [70] Austria Mixed Age, sex, calendar period, area, smoking 2212 Mortality MOR, silicotic 1.41 (1.21–1.64) 182
5 Schuller, 1986 [82] Switzerland Mixed Calendar period 2399 Mortality MOR, silicotic 2.23 (1.90–2.60) 180
6 Tsuda, 2002 [91] Japan Mixed Age, sex, smoking 501 Mortality OR, silicotic 2.77 (1.60–4.77) 184













plots in Figs. 2, 3 and 4 respectively. Significant between-
study heterogeneity was observed in SMR, MOR and SIR
studies with I2 of 96 %, 87 % and 75 % respectively. PMR
and OR studies with mortality as outcome showed lower
between-study heterogeneity (I2 62 % and 51 % respect-
ively), which was statistically insignificant (p value for Q
test >0.10 for both). No heterogeneity was observed in the
meta-analysis of OR studies with incidence as outcome.
Studies conducted in silicotic subjects yielded a signifi-
cantly higher pooled SMR of 2.32 (95 % CI 1.91–2.81) and
SIR of 2.49 (95 % CI 1.87–3.33) as compared to non-
silicotic studies which gave a resulting estimate of 1.78
(95 % CI 1.07–2.96) for SMR studies and 1.18 (95 % CI
0.86–1.62) for SIR studies. Between-study heterogen-
eity was statistically significant in silicotic and non-
silicotic studies with SMR as risk measure (I2 = 94 %
Fig. 2 Forest plot showing pooled standardized mortality ratio (SMR) of lung cancer due to silica dust. SMR, Standardized mortality ratio; RE,
Random effect; I2, Variability due to heterogeneity; Q, Chi-square test for heterogeneity; K, Number of studies
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with p < 0.0001 and I2 = 74 % with p = 0.013 respectively)
but they were found to be lower and statistically insignifi-
cant in silicotic and non-silicotic studies with SIR as meas-
ure of association (I2 = 25 % with p = 0.377 and I2 = 41 %
with p = 0.192) respectively.
Subgroup analyses were carried out individually for
SMR and SIR studies. We could not perform similar
subgroup analysis for the few remaining studies report-
ing other measures of association due to their limited
number. Since the level of between-study heterogeneity
was found to be 0 % in the group of OR studies report-
ing incidence as outcome, we did not perform any fur-
ther analysis to explore heterogeneity. Subgroup analysis
for SMR studies showed a positive association between
silica dust exposure and lung cancer in all subgroups
except in the subgroup of cement industries which had a
pooled risk estimate of 0.87 (95 % CI 0.42–1.82).
Heterogeneity became non-significant (p > 0.10) in the
subgroups of potteries (I2 = 0 % and p = 0.273), construc-
tion industries (I2 = 0 % and p-0.656) and in the sub-
group including studies done in Australia (I2 = 20 % and
p = 0.265). In all other subgroups, between-study hetero-
geneity remained significant. Out of 63 SMR studies,
only 2 adjusted for smoking [28, 102] and the effect
measure in this subgroup was 1.83 (95 % CI 1.51–2.22).
In the subgroup of studies without adjustment for smok-
ing, the pooled estimate was 1.55 (95 % CI 1.37–1.75).
Thirteen SMR studies having none of the other potential
occupational carcinogens mentioned in the Methods
Section yielded an estimate of 1.32 (95 % CI 1.14–1.54).
The positive association between silica and lung cancer
became weaker with increasing quality of the included
studies, from 2.56 (95 % CI 1.57–4.19) among SMR
studies with an NOS score of 1–3 to 1.24 (95 % CI
Fig. 3 Forest plot showing pooled standardized incidence ratio (SIR) of lung cancer due to silica dust. SIR, Standardized incidence ratio; RE,
Random effect; I2, Variability due to heterogeneity; Q, Chi-square test for heterogeneity; K, Number of studies
Fig. 4 Forest plot showing pooled odds ratio (OR) of lung cancer due to silica dust. OR, Odds ratio; RE, Random effect; I2, Variability due to
heterogeneity; Q, Chi-square test for heterogeneity; K, Number of studies
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1.01–1.52) in those with an NOS score of 7–9. A similar
trend was observed among SIR studies.
Subgroup analysis for SIR studies showed a positive re-
lation between occupational silica exposure and risk of
lung cancer in all subgroups, with statistically significant
risk estimates in all subgroups except that including
studies conducted in Canada (p = 0.494). Much of the
between-study heterogeneity could be explained by sub-
grouping the SIR studies and in most of the subgroups,
it became statistically insignificant (p > 0.1). None of the
SIR studies adjusted for smoking. Detailed main statis-
tical analysis, subgroup analyses for SMR and SIR stud-
ies and statistical analysis of silicotic and non-silicotic
studies are shown in Table 2.
Separate meta-regression analyses were performed for
SMR studies, SIR studies and silicotic studies reporting
SMR as risk measure. These were done using both uni-
variate and multivariate models. In the univariate meta-
regression analysis of SMR studies, NOS score was the
most important covariate accounting for 19 % of hetero-
geneity while in the multivariate analysis, the combination
of industrial setting, year of publication, geographical loca-
tion and number of subjects accounted for the maximum
amount of heterogeneity (R2 = 37 %). As for the SIR
studies, univariate analysis showed that total number of
deaths accounted for the highest amount of heterogeneity
(R2 = 100 %) and a combination of number of subjects and
NOS score corrected the maximum amount of heterogen-
eity (R2 = 15 %) in multivariate analysis. Regarding the sili-
cotic studies, the combination of year of publication and
total number of deaths corrected 43 % of between-study
heterogeneity. Detailed results of meta-regression analyses
are shown in Table 3.
For the exposure-response analysis of the relationship
between silica dust and risk of lung cancer, reference
was made to the subgroup analysis of SMR studies by
average level of cumulative silica dust exposure. Nine-
teen studies were included. It was found that the risk of
lung cancer increased with rising exposure level (risk es-
timate rose from 1.19 (95 % CI 1.02–1.39) in the first
quartile to 1.36 (95 % CI 0.87–2.13) in the fourth quar-
tile). However, the p value of the estimate was statisti-
cally insignificant for the second, third and fourth
quartiles (p > 0.05). A high level of between-study het-
erogeneity was also noted especially with rising quartiles
of cumulative silica dust (p < 0.0001).
Sensitivity analyses showed that omission of any study
did not significantly influence the pooled estimates.
Discussion
The present meta-analysis, which combines the results
from 85 different studies, supports the carcinogenicity of
respirable crystalline silica dust on the lung. This posi-
tive trend was observed independent of the measure of
association and of the level of heterogeneity. The pooled
risk estimates in the silicotic studies, which were 2.32
(95 % CI 1.91–2.81) for SMR studies and 2.49 (95 % CI
1.87–3.33) for SIR studies, were found to be higher than
those in non-silicotic studies, which were 1.78 (95 % CI
1.07–2.96) for SMR studies and 1.18 (95 % CI 0.86–1.62)
for SIR studies. Both silicotic and non-silicotic studies in-
clude subjects who are exposed to silica dust. Our results
support the hypothesis that silicosis has a stronger associ-
ation with lung cancer morbidity and mortality than silica
exposure on its own. The positive association between sil-
ica dust and lung cancer in non-silicotic subjects could
probably be due to genetic factors which predispose these
individuals to lung cancer with only a minimal exposure
to silica dust.
Previous meta-analyses have found a positive association
between crystalline silica dust and lung cancer in silicotics
and silica-exposed workers, but in non-silicotics, the associ-
ation was either negative or weakly positive [16, 106–111].
In these published studies, the cohort study subgroups gave
pooled estimates ranging from 1.25 (95 % CI 1.18–1.33) to
1.29 (95 % CI 1.20–1.40) in silica-exposed participants, 1.69
(95 % CI 1.32–2.16) to 2.78 (95 % CI 2.41–3.22) in silicotics
and 1.19 (95 % CI 0.87–1.57) to 1.20 (95 % CI 1.10–1.30) in
non-silicotics. The case-control study subgroups yielded
risk estimates ranging from 1.41 (95 % CI 1.18–1.70) to
1.42 (95 % CI 1.22–1.65) in silica-exposed workers, 1.70
(95 % CI 1.15–2.52) to 3.27 (95 % 1.32–8.20) in silicotics
and from 0.97 (95 % CI 0.68–1.38) to 1.00 (95 % CI 0.70–
1.30) in non-silicotics [13].
Based on the year of publication, we observed a grad-
ual decline in the pooled risk estimate with time from a
pooled SMR of 2.37 (95 % CI 1.76–3.19) and a pooled
SIR of 2.32 (95 % CI 1.50–3.58) in publications before
1991 to a pooled SMR of 1.30 (95 % CI 1.16–1.46) and a
pooled SIR of 1.54 (95 % CI 1.40–1.70) in papers pub-
lished after 2000. Though some of the papers are up-
dates of older ones, the difference between them is the
extended follow-up period in the more recent ones. The
lowering risk of lung cancer in recent years may be due
to more objective outcome assessment and exposure as-
certainment by direct measurement and also due to
lower dust concentration as a result of the improvement
and stricter implementation of dust control measures.
Our study also showed that the risk of lung cancer dif-
fered among various industries. In the SMR studies, the
highest pooled risk estimate of 1.48 (95 % CI 1.18–1.86)
which was statistically significant was observed in the
mining industry. Possible reasons may be due to the
higher level of silica exposure and longer duration of time
spent in dust-laden environment. In the same subgroup,
the lowest risk of lung cancer was observed in the pottery
factories with a risk estimate of 1.14 (95 % CI 1.05–1.23).
This may be because clay coatings decrease the biological
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Table 2 Results of meta-analysis of all studies, silicotic studies and non-silicotic studies and subgroup analyses
Study design (effect measure) Number of studies Effect estimate P value of effect P value of
heterogeneity, Q
I2 P value Egger test
Cohort studies (SMR) 63 1.55 (1.38–1.75) 5.68E-13 <0.0001 96.18 0.02
Cohort studies (SIR) 19 1.68 (1.45–1.96) 1.36E-11 4.59E-08 74.51 0.24
Cohort studies (RR) 1 1.65 (1.13–2.40) 0.01 1 0.72
Case-control mortality studies (OR) 5 1.82 (1.25–2.66) 0.0017 0.1070 51.17 0.51
Case-control incidence studies (OR) 9 1.34 (1.24–1.46) <0.0001 0.2075 0 0.46
Case-control studies (MOR) 3 1.69 (1.26–2.26) <0.0001 <0.0001 86.70 1.00
Proportional mortality studies (PMR) 2 1.10 (0.89–1.36) 0.38 0.10 62.02 1.00
Silicotic studies (SMR) 24 2.32 (1.91–2.81) <0.0001 <0.0001 94.34 -
Silicotic studies (SIR) 4 2.49 (1.87–3.33) <0.0001 0.377 25.04 -
Silicotic studies (OR) 3 2.56 (1.84–3.57) <0.0001 0.345 2.65 -
Silicotic studies (MOR) 3 1.88 (1.31–2.71) 0.0006 <0.0001 86.98 -
Non-silicotic studies (SMR) 4 1.78 (1.07–2.96) 0.027 0.013 74.37 -
Non-silicotic studies (SIR) 2 1.18 (0.86–1.62) 0.292 0.192 41.21 -
Subgroup analysis of SMR studies
Year of publication
≤ 1990 16 2.37 (1.76–3.19) 1.24E-08 2.92E-94 95.58 0.35
1991–2000 21 1.44 (1.21–1.71) 2.97E-05 1.25E-30 89.89 0.16
> 2000 26 1.30 (1.16–1.46) 1.05E-05 9.98E-49 93.50 0.60
Industry
Mine 18 1.48 (1.18–1.86) 0.00 4.73E-59 97.17 0.18
Foundry 4 1.51 (0.99–2.29) 0.05 0.02 86.53 0.75
Pottery 7 1.14 (1.05–1.23) 0.00 0.27 0.02 1.00
Cement 4 0.87 (0.42–1.82) 0.71 <0.0001 84.87 0.75
Construction 2 1.55 (1.31–1.82) 1.94E-07 0.66 0.00 1.00
Stone & granite 8 1.32 (1.15–1.50) 6.24E-05 0.01 65.17 0.72
Mixed 19 2.03 (1.61–2.56) 1.68E-09 96.95 0.73
Country
Europe 26 1.54 (1.25–1.89) 4.95E-05 4.09E-33 95.70 0.13
USA 15 1.24 (1.12–1.38) 6.24E-05 5.32E-07 79.80 0.06
Canada 5 2.14 (1.46–3.13) 9.27E-05 2.34E-32 95.70 0.82
Australia 2 1.73 (1.51–1.98) 7.65E-15 0.26 19.61 1.00
Asia 14 1.74 (1.27–2.39) <0.0001 97.56 0.75
Occupational confounders
Absent 13 1.32 (1.14–1.54) <0.0001 1.79E-13 87.15 0.06
Present 30 1.35 (1.17–1.57) 7.28E-05 7.37E-55 94.47 0.55
Reported measure adjusted for smoking
Not adjusted 61 1.55 (1.37–1.75) 4.16E-12 96.37 0.02
Adjusted 2 1.83 (1.51–2.22) 7.23E-10 0.43 0.00 1.00
NOS score
1–3 6 2.56 (1.57–4.19) 0.00 2.35E-65 96.18 1.00
4–6 35 1.57 (1.36–1.82) 9.02E-10 1.68E-80 93.07 0.45
7–9 15 1.24 (1.01–1.52) 0.042025 1.56E-44 97.23 0.17
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availability of the toxic crystalline silica surfaces, thereby
diminishing or deferring the disease risk. Harrison et al.
found that the percentage of clay coating silica particles
was 45 % in pottery worksites, 18 % in tin mines and 13 %
in tungsten mines [112]. Studies have shown that clay and
aluminum oxide or aluminosilicate surface coatings of res-
pirable crystalline silica particle surfaces can modify the
cytotoxic and fibrogenic activities of crystalline silica
dust [113]. A negative association, with a risk esti-
mate of 0.87 (95 % CI 0.42–1.82), without statistical
significance (p = 0.714) was observed between cement
dust exposure and lung cancer mortality in cement
factory workers in this meta-analysis. A reverse trend
was observed among SIR studies in the subgroup of
cement industries. Possible explanations could be that
cement dust is weakly carcinogenic and cement
factory workers are immediately removed from the
high-risk job as soon as they are diagnosed with any
respiratory problems, thereby decreasing the chance
of progress to more severe disease and mortality.
When conducting a meta-analysis of epidemiological
studies, significant heterogeneity in risk across studies
reflects differences in workplace exposures, assessment
of exposure, data collection processes, population being
studied and, in the case of silica, in the biological activity
of the silica particles. It has been suggested that a vari-
able biological activity of silica particulates might be re-
lated to particle size, time since fracture and presence of
other minerals or dust components that might cover the
silenol radicals on the surface of the silica particles
Table 2 Results of meta-analysis of all studies, silicotic studies and non-silicotic studies and subgroup analyses (Continued)
Cumulative Silica Dust Exposure (CSDE) (mg/m3years)
0 < CSDE ≤ 0.83 5 1.19 (1.02–1.39) 0.02 0.02 68.92 0.23
0.83 < CSDE ≤ 3.9 5 1.27 (0.89–1.82) 0.19 1.04E-24 97.57 0.48
3.9 < CSDE ≤ 8.35 4 1.33 (0.94–1.87) 0.10 2.97E-10 91.94 0.75
CSDE > 8.35 5 1.36 (0.87–2.13) 0.18 1.15E-21 96.33 0.82
Subgroup analysis of SIR studies
Year of publication
≤ 1990 4 2.32 (1.50–3.58) <0.0001 0.07 64.63 0.75
1991–2000 6 1.77 (1.17–2.69) 0.01 5.07E-09 85.81 0.47
> 2000 9 1.54 (1.40–1.70) 8.29E-18 0.41 17.30 1.00
Industry
Mine 2 1.67 (1.32–2.13) 2.55E-05 0.07 69.32 1.00
Foundry 4 1.40 (1.23–1.58) 2.67E-07 0.52 7.15 0.33
Pottery 1 2.34 (0.62–8.84) 0.21 1 0.33
Cement 3 1.34 (1.01–1.76) 0.04 0.43 12.61 1.00
Construction 1 1.50 (1.26–1.79) 5.04E-06 1 1.00
Granite 3 1.94 (1.55–2.44) 1.33E-08 0.93 0.00 1.00
Mixed 5 2.13 (1.18–3.87) 0.01 4.08E-05 85.96 0.82
Country
Europe 13 1.78 (1.48–2.14) 1.16E-09 9.18E-08 77.40 0.13
Canada 2 1.42 (0.52–3.93) 0.49 0.05 74.77 1.00
Australia 1 1.89 (1.57–2.28) 2.26E-11 1 1.00
Asia 3 1.38 (1.10–1.73) <0.0001 0.28 6.72 1.00
Occupational confounders
Absent 3 1.94 (1.55–2.44) 1.33E-08 0.93 0.00 1.00
Present 12 1.57 (1.32–1.87) 4.14E-07 4.45E-08 80.28 0.64
NOS grading
1–3 3 1.99 (1.19–3.30) 0.01 0.95 0.00 1.00
4–6 11 1.55 (1.28–1.87) 5.74E-06 2.36E-08 82.02 0.76
7–9 1 1.61 (1.21–2.14) <0.001 1 0.76
I2 variability due to heterogeneity; R2, SMR standardized mortality ratio, SIR standardized incidence ratio OR odds ratio, MOR mortality odds ratio, PMR proportional
mortality ratio, NOS Newcastle-Ottawa scale
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Table 3 Results of meta-regression analyses
Measure Parameter k Estimate P value estimate P value of Q I2 R2 p covariates
Meta-regression analysis of SMR studies
SMR No covariate 63 1.55 (1.38–1.75) <0.0001 <0.0001 96.18
Univariate model Year of publication 63 2.30E + 18 (2.41E + 08–2.19E + 28) 0.003 <0.0001 95.44 15.12 0.000
Industry 63 1.15 (0.86–1.53) 0.353 <0.0001 95.71 8.15 0.027
Person-years of follow-up 22 1.53 (1.25–1.87) <0.0001 <0.0001 94.73 13.4 0.050
NOS score 63 3.53 (2.27–5.49) <0.0001 <0.0001 95.11 19.18 0.000
Number of subjects 63 1.69 (1.48–1.92) <0.0001 <0.0001 95.43 10.89 0.008
Total number of deaths 54 1.69 (1.48–1.94) <0.0001 <0.0001 95.31 13.94 0.006
Multivariate model Industry, year of publication 63 1.07E + 19 (3.85E + 09-2.97E + 28) <0.0001 <0.0001 94.65 25.51 <0.0001
Industry, year of publication, geographical location 63 1.04E + 20 (4.90E + 10-2.21E + 29) <0.0001 <0.0001 94.3 28.85 <0.0001
Industry, year of publication, geographical location,
number of subjects
63 1.80E + 17 (1.67E + 08-1.94E + 26) <0.0001 <0.0001 93.18 37.41 <0.0001
Industry, year of publication, geographical location,
number of subjects, NOS score
63 1.06E + 16 (5.27E + 06-2.12E + 25) 0.001 <0.0001 93.05 37.04 <0.0001
Industry, year of publication, geographical location,
number of subjects, total deaths
54 5.32E + 18 (1.07E + 08-2.65E + 29) 0.001 <0.0001 92.72 34.76 <0.0001
Industry, year of publication, geographical location,
NOS score
63 1.29E + 17 (3.61E + 07-4.61E + 26) <0.0001 <0.0001 93.77 32.23 <0.0001
Person-years of follow-up, industry 22 1.22 (0.76–1.96) 0.408 <0.0001 94.12 13.87 0.086
Person-years of follow-up, industry, year of publication 22 2.80E + 14 (2.88E-08-2.73E + 36) 0.198 <0.0001 92.81 17.99 0.079
Person-years of follow-up, industry, year of publication,
geographical location
22 1.55E + 23 (4.66E-02-5.12E + 47) 0.064 <0.0001 92.31 23.08 0.056
Person-years of follow-up, number of subjects 22 1.62 (1.31–2.00) <0.0001 <0.0001 92.9 17.36 0.055
Meta-regression analysis of SIR studies
SIR No covariate 19 1.68 (1.45–1.96) <0.0001 <0.0001 74.51
Univariate model Year of publication 19 7.92E + 11 (3.71E-02-1.69E + 25) 0.080 <0.0001 72.31 4.27 0.086
Industry 19 1.37 (0.97–1.95) 0.077 <0.0001 70.88 11.68 0.214
Number of subjects 19 1.88 (1.55–2.28) <0.0001 <0.0001 69.94 18.16 0.086
Total number of deaths 5 1.29 (1.05–1.59) 0.017 0.687 0 100 0.017
Multivariate model Number of subjects, exposure level 19 2.09 (1.47–2.96) <0.0001 <0.0001 72.12 9.02 0.197
Number of subjects, NOS score 19 3.01 (1.52–5.95) 0.002 <0.0001 69.36 15.16 0.087













Table 3 Results of meta-regression analyses (Continued)
Meta- regression of silicotic studies
SMR Year of publication 24 7.03E + 21 (5.05E + 04-9.79E + 38) 0.013 <0.0001 92.23 20.55 0.014
Year of publication, total number of deaths 20 1.59E + 23 (1.60E + 05-1.57E + 41) 0.012 <0.0001 86.98 42.87 0.002
Year of publication, total number of deaths, geographical
location, industry
20 4.61E + 22 (2.40E + 03-8.85E + 41) 0.021 <0.0001 86.9 33.84 0.022
Year of publication, total number of deaths, industry 20 6.07E + 22 (1.43E + 04-2.58E + 41) 0.017 <0.0001 87.46 38.8 0.002
Year of publication, total number of deaths, geographical
location
20 9.89E + 22 (2.24E + 04-4.37E + 41) 0.016 <0.0001 86.65 38.3 0.007
Year of publication, geographical location 24 1.26E + 22 (3.90E + 04-4.08E + 39) 0.013 <0.0001 92.05 16.98 0.050














[114]. We were able to explore sources of heterogeneity
to varying extent in our study through meta-regression
analysis (up to 100 % heterogeneity could be corrected
when total number of deaths was used as covariate in the
univariate analysis of SIR studies). Higgins commented
that heterogeneity is an inevitable part of a meta-analysis
and that any amount of heterogeneity is acceptable,
provided the predefined eligibility criteria for the meta-
analysis are sound and the data are correct, both of which
have been duly verified in this study [18].
The exposure-response analysis showed that the
higher the level of cumulative silica dust exposure, the
more is the risk of lung cancer. However, the high level
of heterogeneity limits any inference of causality. Wrong
estimation of the level and duration of exposure of
workers, varying measurement methods and incorrect
data collection may lead to significant between-study
heterogeneity in the determination of an exposure-
response relationship. Similar findings were obtained in
the dose-response meta-analysis of silica and lung cancer
using 4 cohort and 6 case-control studies performed by
Lacasse et al. [16].
The first strength of our meta-analysis is that we have
tried to include the maximum number of relevant stud-
ies published till date. The number and variety of studies
included in a meta-analysis are sometimes reduced to in-
crease the homogeneity of the studies evaluated. How-
ever, this potentially reduces the amount of information
on factors that influence the outcome of individual stud-
ies. To our knowledge, our meta-analysis is the largest
one conducted on this topic. Secondly, we conformed to
the PRISMA guidelines for a systematic and objective
data analysis. Thirdly, subgroup and meta-regression
analyses have allowed us to explore in more detail the
issue of heterogeneity which, as expected was substan-
tially high. Fourthly, we have been able to explore the
exposure-response relationship between occupational
exposure to silica dust and risk of lung cancer.
Two main limitations of our study should be noted.
First is the ensuing risk of bias of the included studies.
Although publication bias was not detected from funnel
plots and by Egger’s regression test of OR and SIR stud-
ies, it was found to be significant (p < 0.05) for SMR
studies. The most important factors that can account for
confounding bias in the interpretation of the results are
cigarette smoking and occupational carcinogens includ-
ing radon, arsenic, PAH, diesel, talc, cadmium and
asbestiform fibers. When we compared the pooled risk
estimate of smoking-adjusted SMR studies with that of
the unadjusted studies, we found that cigarette smoking
does not account for increased risk of lung cancer
among silica-exposed workers. We obtained similar re-
sults by subdividing SMR studies into those with poten-
tial exposure to occupational confounders and those
excluding their presence. These findings imply that the
presence of other potential lung carcinogens in silica-
exposed jobs does not suggest a confounding effect on
the positive relationship between silica and lung cancer.
Observational studies are also prone to biases due to se-
lection of study population and loss to follow-up. It is,
however difficult to completely control or eliminate all
bias when designing or performing an observational
study [115]. Our meta-analysis has made an attempt to
address this limitation by conducting subgroup analysis
based on NOS score. We found that the lower-quality
studies tend to overestimate the effect measure, probably
due to reliance on self-reporting rather than objective
assessment of outcome and indirect methods of meas-
urement of past exposure to silica dust among workers.
Self-reporting are usually subject to recall bias leading to
exposure and outcome misclassification and overesti-
mation of risk estimates. Second drawback is the high
degree of between-study heterogeneity noted except in
the group of case-control studies with incidence as
outcome.
We have shown, through this meta-analysis that the
risk of lung cancer is higher in workers exposed to crys-
talline silica dust but the exact mechanism of carcino-
genicity in human beings are yet to be determined.
Three mechanisms have been proposed based on experi-
mental studies in animals. First, exposure to crystalline
silica impairs alveolar-macrophage-mediated particle
clearance thereby increasing persistence of silica in the
lungs, which results in macrophage activation, and the
sustained release of chemokines and cytokines. In rats,
persistent inflammation is characterized by neutrophils
that generate oxidants that induce genotoxicity, injury
and proliferation of lung epithelial cells leading to the
development of lung cancer. Second, extracellular gener-
ation of free radicals by crystalline silica depletes antioxi-
dants in the lung-lining fluid. Third, crystalline silica
particles are taken up by epithelial cells followed by
intracellular generation of free radicals that directly
induce genotoxicity. The IARC considers the first mech-
anism as the most prominent based on the current
experimental data using inhalation or intratracheal in-
stillation in rats, although the other mechanisms cannot
be excluded. More research has been recommended in
this particular field [13].
Conclusion
To conclude, this paper supports the positive association
of crystalline silica and lung cancer and the existence of
an exposure-response relationship between these two,
with a high degree of heterogeneity in the analyses. The
risk tends to be more pronounced in the presence of sili-
cosis and in the mining industry and is not significantly
affected by the presence or exclusion of occupational
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confounding factors or by adjustment for cigarette
smoking. A gradual reduction in the risk with time has also
been noted. Further research is needed to find out whether
non-silicotics are truly at risk, whether a predisposing
factor would explain this potential risk and to determine
the mechanism of carcinogenicity of silica in humans.
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